Dapagliflozin 5mg is an oral antidiabetic medication belonging to the SGLT2 (Sodium-Glucose Cotransporter-2) inhibitor class. It works by preventing glucose reabsorption in the kidneys, promoting glucose excretion through urine, and thereby helping control blood sugar levels in adults with type 2 diabetes mellitus. Dapagliflozin is effective as monotherapy or in combination with other antidiabetic agents such as metformin, insulin, or sulfonylureas. Regular use may also provide cardiovascular and renal benefits in certain patients.
